Care365.caYour health is one click away
Menu
Vaccine product guide

INFANRIX-IPV/HIB

DTaP-IPV-Hib · Tetanus, diphtheria, pertussis, polio, Hib (DTaP / Tdap / Td)

Health Canada DIN 02257122. Check the product and formulation on your record before using a schedule.

Plan doses for this product →
DIN
02257122
Family
DTaP / Tdap / Td
Guidance checked
2026-09-27
← All Tetanus, diphtheria, pertussis, polio, Hib (DTaP / Tdap / Td) products

About this vaccine

INFANRIX-IPV/Hib is a vaccine given to babies and young children to protect them against five serious diseases: diphtheria, tetanus, whooping cough (pertussis), polio, and Haemophilus influenzae type b (Hib) infection.

INFANRIX-IPV/HIB is listed under Health Canada DIN 02257122. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.

At a glance

Brand
INFANRIX-IPV/HIB
DIN
02257122
Vaccine
DTaP-IPV-Hib
Presentation
0.5 mL · suspension · intramuscular · 6 weeks to 6 years
Live vaccine
No

Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.

Official sources

Use the DIN to confirm this exact product in Health Canada's Drug Product Database.

A listed product may not be stocked or publicly funded.

Before and after your vaccination

  • Bring your immunization record if you have one, so earlier doses can be checked.
  • Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
  • After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
  • Keep a record of the vaccine name, date and dose you received.

These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.

Practical guidance for INFANRIX-IPV/HIB

The details below are adapted from a Pharmasist patient handout linked to the same product monograph. The current Canadian Immunization Guide determines the dose schedules shown later.

What this vaccine helps prevent

  • INFANRIX-IPV/Hib is a vaccine given to babies and young children to protect them against five serious diseases: diphtheria, tetanus, whooping cough (pertussis), polio, and Haemophilus influenzae type b (Hib) infection.

What to mention before a dose

  • Tell the nurse or doctor if your child has ever had an allergic reaction to a previous dose of this vaccine or to any vaccine containing similar ingredients.
  • Tell the nurse or doctor if your child is currently sick with a moderate or severe illness or has a high fever; vaccination may need to be postponed until they feel better. A mild cold with a low fever is usually not a reason to wait.
  • Tell the nurse or doctor about your child's full vaccination history, including any past reactions to vaccines.
  • Tell the nurse or doctor if your child was born very prematurely, has a bleeding disorder, or has a neurological condition such as epilepsy.

How it is given

  • This vaccine is given as a shot into the muscle, usually in your child's thigh, by a nurse or doctor.
  • You do not need to do anything to prepare. Your healthcare provider will handle mixing and giving the vaccine.

Important things to know

  • Fainting can happen after any vaccination, so your child may be watched for a short time afterward.
  • If your child has had a serious brain reaction, such as prolonged unresponsiveness, within a week of a previous whooping-cough-containing vaccine, tell your healthcare provider before the next dose.
  • Very premature babies may need to have their breathing monitored for a couple of days after their first vaccine doses.

Effects you may notice

  • Soreness, redness, or swelling where the shot was given
  • A mild fever
  • Fussiness or crying
  • Reduced appetite
  • Sleepiness
  • Diarrhea or vomiting
  • Runny nose or cough

When to contact a healthcare professional

  • If your child has a high fever that does not go down
  • If the injection site swelling or redness is getting worse instead of better

When to get emergency help

  • Signs of a severe allergic reaction, such as swelling of the face or throat, hives, or trouble breathing
  • A seizure
  • Your child becomes unusually limp, pale, and unresponsive
  • Swelling that spreads over the child's entire arm or leg, especially with a fever

Other medicines and vaccines

  • This vaccine has no known interaction with food.
  • Tell your healthcare provider about any medicines that weaken the immune system, such as steroids or chemotherapy, since these can lower how well the vaccine works.
  • This vaccine can usually be given at the same visit as other routine childhood vaccines, using separate needles in different spots.

Key points to remember

  • Bring your child's vaccination record to every appointment.
  • Mild side effects like soreness and a low fever are normal and usually go away within a couple of days.

The practical points are adapted from the Pharmasist reference for INFANRIX-IPV/HIB and its matching product monograph.

Dose schedules

These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.

DTaP-IPV-Hib — infant series (2, 4, 6 and 18 months)

4 doses

Four doses at 2, 4, 6 and 18 months of age.

Routine infant series with a DTaP-IPV-Hib-containing vaccine at 2, 4, 6 and 12 to 23 months (generally 18 months); the first dose can be given as early as 6 weeks. Minimum 4 weeks between primary doses and 6 months between dose 3 and the booster. Late starters follow a catch-up schedule set by your clinician.

Check your dose plan →

Pregnancy and breastfeeding

Family guidance on pregnancy: Tdap is recommended in every pregnancy, irrespective of immunization history, ideally at 27 to 32 weeks. Polio (IPV) may be considered for a non-immune person at increased risk; Hib when a predisposing condition is present.

Family guidance on breastfeeding: Tdap is recommended if no adult dose has been given; polio and Hib are used if indicated.

This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.

References and product information

General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.

Explore care options